ATLANTA–(BUSINESS WIRE)–#AzaleaHealth—Azalea Health Innovations Inc. (Azalea Health or Azalea), a leading provider of cloud-based patient management and health IT solutions, today announced it has emerged as a Small Practice Ambulatory electronic medical record (EMR)/practice management (PM) contender in the 2022 Best in KLAS: Software and Services report.
In its inaugural year of being highlighted in the Best in KLAS Report, Azalea received an 88.7 overall performance score including an A for culture, an A- for product and value. The Best in KLAS report highlights both the ranked and not ranked solutions in each category, enabling providers to understand the broad options of solutions per category.
The Best in KLAS report recognizes software and services companies who excel in helping healthcare professionals improve patient care. All rankings are a direct result of the feedback of thousands of providers over the last year. A Best in KLAS award signifies to the healthcare IT industry the commitment and partnership that the top vendors should provide.
The category Small Practice Ambulatory EMR/PM (≤10 Physicians) includes vendor solutions providing both an electronic medical record (EMR) and practice management (PM) solution used by small practices. EMR solutions provide charting, orders, prescriptions, and/or other EMR functionality; practice management solutions focus on patient registration, scheduling, and billing.
“We are honored to be included in this prestigious report,” said Baha Zeidan, CEO of Azalea Health. “This being our first year, we are pleased to see our overall performance score, which places us in the lead of the Small Practice Ambulatory EMR/PM ranking. We look forward to advancing in the ranking and emerging even stronger and officially ranked in the 2023 report and subsequent versions.”
About the Best in KLAS Report
KLAS makes thousands of proactive calls each year to collect the research necessary for the annual report. In every instance, the KLAS methodology includes screening for bias to ensure as clean and random a sample as possible. To learn more about KLAS’ research process and methodology, please visit https://klasresearch.com/klas-model.
About Azalea Health
Azalea Health Innovations (Azalea) is on a mission to empower underserved healthcare providers with a health IT platform that improves patient care and profitability. Offering a 100% cloud-based integrated platform, Azalea delivers electronic health records, revenue cycle management, data insights and telehealth solutions designed for rural and community practices and hospitals. Quick to deploy and intuitive to use, Azalea solutions ensure better care coordination and communication – enabling better outcomes and a meaningful competitive advantage. The Azalea platform also provides tools and resources to help clients meet their regulatory requirements, as well as strategies to navigate accountable care and alternative payment models. Above all, Azalea strives to deliver a simplified EHR experience that is loved by all who use it. For more information, visit http://www.azaleahealth.com.
About KLAS Research
KLAS is a data-driven company on a mission to improve the world’s healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance.
For more information on the 2017-2022 Best in KLAS: Software and Services reports, January, © KLAS 2022, visit www.klasresearch.com.
Contacts
Media Contact:
John Walker
Chirp for Azalea Health
john@chirppr.com
At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response…
Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK…
The study met its primary endpoint of overall survival with a 41% reduction in the…
DENVER, CO / ACCESSWIRE / June 15, 2024 / Each year over 120,000 Coloradans are…
REYKJAVIK, Iceland, June 15, 2024 /PRNewswire/ -- In a recent display of global baking talent,…
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha-…